Standards & Regulations Medical electrical equipment safety
By Itoro Udofia, director, medical health service at TÜV SÜD, a global product testing and certification organisation
I
EC 60601 is a series of technical standards that ensure the safety of medical electrical equipment. Public health authorities in many countries recognise the standard as a pre-requisite for the commercialisation of electrical medical equipment, so its requirements must be met in different markets around the globe.
It is relevant to manufacturers of medical electrical equipment and systems, and those that manufacture components of medical electrical equipment. The standard series includes, but is not limited to, requirements regarding electrical hazards, mechanical hazards, the spread of fire from the equipment, as well as laser sources and sonic and ultrasonic pressure. It is also applicable for in vitro diagnostic (IVD) medical purposes, including self-test IVD medical purposes. This standard adds further product-specific requirements for IVD medical equipment to the general standard such as biohazards and hazardous chemical substances.
The rapid technological changes in medical equipment have necessitated prompt revisions to safety standards. The second amendment to the third edition of the medical standard (IEC 60601-1, Edition 3.2) improved the previous version as it revised outdated references, provided more definitions, and clarified technical issues that manufacturers may have experienced with previous versions. Some of the updates were also intended to align the standards with other regulatory requirements and updates that had been made to relevant medical standards, such as ISO 14971, IEC 62366-1 and IEC 62304, to simplify the regulatory approval process. IEC 61010-1 is the general standard for safety requirements for electrical equipment for measurement, control and laboratory use. Electrical equipment for laboratory refers to: ● Equipment that measures, indicates, monitors, inspects, or analyses materials, or is used to prepare materials
● In vitro diagnostic (IVD) equipment including self-test IVD equipment to be used in the home
● Inspection equipment to be used to check people or material during transportation
20 June 2024
Edition 3.2 has around 1,500 single specific requirements. It deals with the general requirements concerning basic safety and essential performance for medical electrical equipment and systems, and serves to ensure that, in both normal conditions and fault conditions, no single electrical, mechanical, thermal or functional failure shall pose an unacceptable risk to patients and/or operators. E.g. related to electrical, mechanical, thermal and functional hazards.
Edition 3.2 includes updates in the areas of risk management, software and usability, use of power supply units, use of safety signs, indicator lights and alarm indicators, maximum over-current protection, insulation components, testing & measuring, components that may pose a threat, mechanical and thermal hazards, lasers and optical radiation, ME systems, and EMC planning. Regulatory bodies across key markets require compliance to IEC 60601, with countries and regions such as the USA, Europe and Asia requiring medical devices to comply with the standard before manufacturers can launch these products in their markets. The requirements are often recognised as State-of- the-Art (SOTA), which means that for medical
Components in Electronics
devices, this is what is currently accepted as good practice in technology and medicine, not necessarily the most technologically advanced solution.
Manufacturers therefore have to take into account SOTA during the design and construction phase. During the following production phase, manufacturers have to take into account all changes in standards and scientific knowledge (SOTA) within the framework of their risk management system, until no more new products are placed on the market. The risk management approach requires manufacturers to recognise new internal standards as part of new scientific knowledge. As a minimum, manufacturers have to conduct a gap analysis if new harmonised standards are issued, or new scientific knowledge is available. Gap analysis means retesting, re-evaluation and, if necessary, redesign of the medical device. Medical device manufacturers must also be aware of the varying regulatory transition periods worldwide for IEC 60601-1, Edition 3.2 and navigating the requirements across different markets can therefore be complicated. For example, a transition period of three to four years has been given in most
countries and regions, so these transition periods are not set as a standard period of time across all countries. However, it is also possible that some countries will require standard compliance with the predecessor standard (Edition 3.1) for a longer time. IEC 60601-1 is a widely accepted standard in the U.S., Canada, the EU, Japan, Brazil, Russia and Australia. To avoid being denied entry into these and other markets, manufacturers with the goal to go worldwide on the market should therefore ensure that their products comply with both Edition 3.1 and 3.2 of the standard. As version 3.2 includes a multitude of many small changes (78 in all), it would normally be considered wise to instigate a gap analysis for all existing products, to ensure that they will meet the new requirements set out in 3.2 edition. However, in reality, the vast majority of manufacturers are conducting testing according to the new standard edition, instead of conducting a gap analysis. This is because new test reports are required anyway for other international approvals and the effort involved is usually comparable.
www.tuvsud.com/en-gb/industries/ healthcare-and-medical-devices
www.cieonline.co.uk.uk
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60
